Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Cash to Debt 0.01
AMRS's Cash to Debt is ranked lower than
99% of the 1103 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.60 vs. AMRS: 0.01 )
Ranked among companies with meaningful Cash to Debt only.
AMRS' s Cash to Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.65 Max: N/A
Current: 0.01
Equity to Asset -1.63
AMRS's Equity to Asset is ranked lower than
99% of the 1068 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 0.55 vs. AMRS: -1.63 )
Ranked among companies with meaningful Equity to Asset only.
AMRS' s Equity to Asset Range Over the Past 10 Years
Min: -1.63  Med: -0.23 Max: 0.87
Current: -1.63
-1.63
0.87
F-Score: 3
Z-Score: -17.38
M-Score: -6.49
WACC vs ROIC
19.95%
-2509.95%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating margin (%) -227.34
AMRS's Operating margin (%) is ranked lower than
97% of the 1083 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 6.79 vs. AMRS: -227.34 )
Ranked among companies with meaningful Operating margin (%) only.
AMRS' s Operating margin (%) Range Over the Past 10 Years
Min: -434.9  Med: -252.28 Max: -98.14
Current: -227.34
-434.9
-98.14
Net-margin (%) -165.14
AMRS's Net-margin (%) is ranked lower than
97% of the 1086 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 4.56 vs. AMRS: -165.14 )
Ranked among companies with meaningful Net-margin (%) only.
AMRS' s Net-margin (%) Range Over the Past 10 Years
Min: -638.16  Med: -200.03 Max: 5.28
Current: -165.14
-638.16
5.28
ROA (%) -82.49
AMRS's ROA (%) is ranked lower than
98% of the 1113 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 3.98 vs. AMRS: -82.49 )
Ranked among companies with meaningful ROA (%) only.
AMRS' s ROA (%) Range Over the Past 10 Years
Min: -135.25  Med: -55.57 Max: 1.1
Current: -82.49
-135.25
1.1
ROC (Joel Greenblatt) (%) -81.51
AMRS's ROC (Joel Greenblatt) (%) is ranked lower than
96% of the 1105 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 12.59 vs. AMRS: -81.51 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
AMRS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -193.95  Med: -146.73 Max: 25.82
Current: -81.51
-193.95
25.82
Revenue Growth (3Y)(%) -40.80
AMRS's Revenue Growth (3Y)(%) is ranked lower than
97% of the 944 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.70 vs. AMRS: -40.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
AMRS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -53.5 Max: -40.8
Current: -40.8
EBITDA Growth (3Y)(%) -33.60
AMRS's EBITDA Growth (3Y)(%) is ranked lower than
95% of the 847 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.10 vs. AMRS: -33.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
AMRS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -34.5 Max: -17.7
Current: -33.6
EPS Growth (3Y)(%) -21.50
AMRS's EPS Growth (3Y)(%) is ranked lower than
86% of the 757 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 8.10 vs. AMRS: -21.50 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
AMRS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: 0  Med: -35.6 Max: -21.5
Current: -21.5
» AMRS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with AMRS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Chemicals » Specialty Chemicals    NAICS: 325199    SIC: 2899
Compare:NYSE:ODC, OTCPK:CXUSF, NYSE:KMG, NAS:TVIA, NYSE:OMN, NAS:GURE, OTCPK:ECSNF, NAS:SYMX, NAS:NTIC, OTCPK:LPAD, NAS:HWKN, NAS:SNMX, NAS:GEVO, OTCPK:LWLG, OTCPK:APGMF, OTCPK:DTRX, NAS:AMTX, NAS:IKNX, OTCPK:NANX, NAS:TORM » details
Traded in other countries:3A0.Germany,
Amyris Inc is a renewable products company engaged in providing sustainable alternatives to petroleum-sourced products. It developed microbial engineering and screening technologies that modify the way microorganisms process sugars.

Amyris Inc was incorporated in California on July 17, 2003 and reincorporated in Delaware on June 10, 2010. The Company is a renewable products company engaged in providing sustainable alternatives to petroleum-sourced products. It developed microbial engineering and screening technologies that modify the way microorganisms process sugars. The Company is engaged in developing various products to address five identified markets including cosmetics, lubricants, flavors and fragrances, performance materials, and transportation fuels. The Company is using its proprietary synthetic biology platform to design microbes, mainly yeast, and use them as living factories in established fermentation processes to convert plant-sourced sugars into renewable hydrocarbons. The Company is developing, and, in some cases, already commercializing, products from these hydrocarbons in several target markets, including cosmetics, lubricants, flavors and fragrances, performance materials, and transportation fuels. It calls these No Compromise products because it designs them to perform comparably to currently available products. The Company's first commercialization efforts have been focused on a renewable hydrocarbon molecule called farnesene Biofene, which forms the basis for various products varying from specialty chemical applications to transportation fuels, such as diesel. In addition, the Company has entered into various contract manufacturing agreements to support commercial production. The Company had 413 issued U.S. and foreign patents and 295 pending U.S. and foreign patent applications that are owned by or licensed to it. The Company is subject to a various federal, state, local and international laws, regulations and permit requirements governing the use, generation, manufacture, transportation, storage, handling and disposal of these materials in the United States, Brazil and other countries where it operates.

Ratios

vs
industry
vs
history
P/S 3.12
AMRS's P/S is ranked lower than
77% of the 1057 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.20 vs. AMRS: 3.12 )
Ranked among companies with meaningful P/S only.
AMRS' s P/S Range Over the Past 10 Years
Min: 0.52  Med: 3.56 Max: 9.58
Current: 3.12
0.52
9.58
EV-to-EBIT -7.12
AMRS's EV-to-EBIT is ranked lower than
99.99% of the 881 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 14.72 vs. AMRS: -7.12 )
Ranked among companies with meaningful EV-to-EBIT only.
AMRS' s EV-to-EBIT Range Over the Past 10 Years
Min: -275.9  Med: -2.3 Max: 15
Current: -7.12
-275.9
15
EV-to-EBITDA -9.06
AMRS's EV-to-EBITDA is ranked lower than
99.99% of the 912 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 11.19 vs. AMRS: -9.06 )
Ranked among companies with meaningful EV-to-EBITDA only.
AMRS' s EV-to-EBITDA Range Over the Past 10 Years
Min: -27.2  Med: -2.4 Max: 35.2
Current: -9.06
-27.2
35.2
Current Ratio 0.16
AMRS's Current Ratio is ranked lower than
99% of the 1071 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.79 vs. AMRS: 0.16 )
Ranked among companies with meaningful Current Ratio only.
AMRS' s Current Ratio Range Over the Past 10 Years
Min: 0.16  Med: 1.38 Max: 11.36
Current: 0.16
0.16
11.36
Quick Ratio 0.10
AMRS's Quick Ratio is ranked lower than
99% of the 1071 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.31 vs. AMRS: 0.10 )
Ranked among companies with meaningful Quick Ratio only.
AMRS' s Quick Ratio Range Over the Past 10 Years
Min: 0.09  Med: 1.24 Max: 11.22
Current: 0.1
0.09
11.22
Days Inventory 76.56
AMRS's Days Inventory is ranked lower than
60% of the 1043 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 64.81 vs. AMRS: 76.56 )
Ranked among companies with meaningful Days Inventory only.
AMRS' s Days Inventory Range Over the Past 10 Years
Min: 11.23  Med: 42.83 Max: 139.58
Current: 76.56
11.23
139.58
Days Sales Outstanding 38.01
AMRS's Days Sales Outstanding is ranked higher than
79% of the 867 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 59.38 vs. AMRS: 38.01 )
Ranked among companies with meaningful Days Sales Outstanding only.
AMRS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 7.75  Med: 22.19 Max: 73.27
Current: 38.01
7.75
73.27
Days Payable 110.93
AMRS's Days Payable is ranked higher than
85% of the 829 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 49.64 vs. AMRS: 110.93 )
Ranked among companies with meaningful Days Payable only.
AMRS' s Days Payable Range Over the Past 10 Years
Min: 10.32  Med: 62.01 Max: 110.93
Current: 110.93
10.32
110.93

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -44.20
AMRS's 3-Year Average Share Buyback Ratio is ranked lower than
95% of the 464 Companies
in the Global Specialty Chemicals industry.

( Industry Median: -1.70 vs. AMRS: -44.20 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AMRS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -143.6  Med: -20.5 Max: 0
Current: -44.2
-143.6
0

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 0.88
AMRS's Price/Median PS Value is ranked higher than
80% of the 940 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 1.27 vs. AMRS: 0.88 )
Ranked among companies with meaningful Price/Median PS Value only.
AMRS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.35  Med: 1.11 Max: 2.73
Current: 0.88
0.35
2.73
Earnings Yield (Greenblatt) (%) -13.98
AMRS's Earnings Yield (Greenblatt) (%) is ranked lower than
93% of the 1086 Companies
in the Global Specialty Chemicals industry.

( Industry Median: 5.20 vs. AMRS: -13.98 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
AMRS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: -14.48  Med: 7.7 Max: 8.7
Current: -13.98
-14.48
8.7

More Statistics

Revenue (TTM) (Mil) $54.80
EPS (TTM) $ -0.30
Beta0.02
Short Percentage of Float12.04%
52-Week Range $0.31 - 1.81
Shares Outstanding (Mil)263.02

Analyst Estimate

Dec16 Dec17
Revenue (Mil $) 84 166
EPS ($) -0.32 -0.12
EPS w/o NRI ($) -0.32 -0.12
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for AMRS

Headlines

Articles On GuruFocus.com
Weekly CEO Sells Highlights Jun 21 2016 
Insiders Top Buys: Amyris Inc. Aug 07 2015 
Weekly CEO Sells Highlight: Netlist Inc, LifePoint Hospitals Inc, Amyris Inc, and Sapient Corp. May 25 2014 
Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
Weekly CEO Sells Highlight: Amyris, AtriCure, 3D Systems Corporation and Cooper Tire & Rubber Compan Sep 10 2012 
Weekly CFO Sells Highlight: SCHW, TIBX, IL, AMRS, BCR, CCOI, CBST Apr 24 2011 
Weekly CEO Sells Highlight: MU, CRIS, HIL, and AMRS Apr 03 2011 

More From Other Websites
AMYRIS, INC. Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an... Dec 09 2016
Amyris Partners with Queensland to Create the leading Industrial Biotechnology Hub in Southeast Asia Dec 06 2016
AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Dec 02 2016
Amyris Signs Multi-Year Collaboration Extension with Kuraray Dec 01 2016
Weakness Seen in Amyris (AMRS) Estimates: Should You Stay Away? Nov 29 2016
Amyris to Present at Four Upcoming Investor Conferences in December Nov 22 2016
Amyris to Present at Four Upcoming Investor Conferences in December Nov 22 2016
AMYRIS, INC. Files SEC form 8-K, Other Events Nov 18 2016
ETFs with exposure to Amyris, Inc. : November 18, 2016 Nov 18 2016
AMYRIS, INC. Financials Nov 17 2016
AMYRIS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct... Nov 16 2016
Amyris Achieves Key Milestone in Major Drug Discovery Collaboration Nov 16 2016
Amyris Achieves Key Milestone in Major Drug Discovery Collaboration Nov 16 2016
AMYRIS, INC. Files SEC form 10-Q, Quarterly Report Nov 09 2016
ETF’s with exposure to Amyris, Inc. : November 7, 2016 Nov 07 2016
AMYRIS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Nov 04 2016
Amyris, Inc. :AMRS-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016 Nov 04 2016
Arzeda Scales High-throughput, Automated Molecule Development Pipeline Nov 03 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)